Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995.
Aims To determine the prevalence of common, serious. concomitant conditions complicating admissions with heart failure and how such conditions influence the length of hospital stay.
Methods and Results Data from Scottish morbidity records (SMRI) were used to determine the rate of deaths and discharges for heart failure (ICD-9 428.0,428.1,428.9). concomitant discharge diagnoses and length of stay in 1995. 27 477 SMRI records listing heart failure as a diagnosis were identified with heart failure in the first position in 11 560 (42%) records. 63.3% of deaths or discharges resulted from emergency admissions. 13.2% of admissions were associated with acute myocardial infarction. 7.3% with angina or chest pain. 11.8% with chronic airways obstruction, 8.3% with chronic or acute renal failure and 5.3% had had a stroke.
Length of stay including those patients who died was 7.6 days when acute myocardial infarction was the principal diagnosis but 26.3 days when stroke was the principal diagnosis.
Conclusion A large proportion of deaths and discharges for heart failure are associated with conditions other than heart failure that may precipitate. contribute to or complicate admission.
Treatment for heart failure that does not also seek to reduce the risk associated with common concomitant diseases may miss opportunities to reduce the overall risk of hospitalization.
Mots-clés Pascal : Insuffisance cardiaque, Homme, Hospitalisation, Ecosse, Grande Bretagne, Royaume Uni, Europe, Durée, Association morbide, Mortalité, Morbidité, Facteur risque, Exploration, Prévalence, Incidence, Epidémiologie, Appareil circulatoire pathologie, Cardiopathie
Mots-clés Pascal anglais : Heart failure, Human, Hospitalization, Scotland, Great Britain, United Kingdom, Europe, Duration, Concomitant disease, Mortality, Morbidity, Risk factor, Exploration, Prevalence, Incidence, Epidemiology, Cardiovascular disease, Heart disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0362664
Code Inist : 002B12A01. Création : 25/01/1999.